Explogen LLC (EXG) is a small Ukrainian enterprise formed in mid-2019 in Lviv, which deploys biological approaches to access the chemical diversity encrypted within bacterial genomes. The company is organized and led by researchers with the in-depth experience in synthetic biology of microorganisms, genomics and bioinformatics. Explogen represents in Ukraine a unique case of research-intensive biotech startup. Its main asset is team of experienced researchers who honed their skills in top institutions - such as Universities of Saarland and Cambridge, Harvard University, Boston University. Their decision to work in home country is driven by the idea to develop a world-class research program, which would contribute to positive changes in Ukrainian science and society.